John R. Brinkley, Kansas physician, and the goat gland rejuvenation fad.

Pharos Alpha Omega Alpha Honor Med Soc

Department of English, Washburn University, Topeka, Kansas, USA.

Published: October 2002

Download full-text PDF

Source

Publication Analysis

Top Keywords

john brinkley
4
brinkley kansas
4
kansas physician
4
physician goat
4
goat gland
4
gland rejuvenation
4
rejuvenation fad
4
john
1
kansas
1
physician
1

Similar Publications

Reversible Junctional Scotoma From Pituitary Adenoma During Pregnancy.

J Neuroophthalmol

December 2024

LSU Health Shreveport School of Medicine (MJN), Shreveport, Louisiana; and Departments of Ophthalmology, Neurology, and Neurosurgery (JJB), LSU Health Shreveport School of Medicine, Shreveport, Louisiana.

View Article and Find Full Text PDF

Renal cell carcinoma metastatic to the orbit in a patient with Wegener granulomatosis.

J Neuroophthalmol

March 2015

Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa Department of Rheumatology, University of Iowa, Iowa City, Iowa Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa Department of Radiology, University of Iowa, Iowa City, Iowa Department of Ophthalmology and Visual Sciences, University of Iowa; Department of Pathology, University of Iowa; and Ophthalmology Service, Iowa City VA Medical Center, Iowa City, Iowa Department of Ophthalmology and Visual Sciences, University of Iowa; Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa Department of Ophthalmology and Visual Sciences, University of Iowa; Ophthalmology Service, Iowa City VA Medical Center, Iowa City, Iowa Department of Ophthalmology and Visual Sciences, University of Iowa; Department of Neurology, University of Iowa; Neurology Service, Iowa City VA Medical Center, Iowa City, Iowa.

View Article and Find Full Text PDF

Cellular kinetics of murine lung: model system to determine basis for radioprotection with keratinocyte growth factor.

Int J Radiat Oncol Biol Phys

February 2004

Department of Experimental Radiation Oncology, Box 066, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Purpose: Normal tissue toxicity remains a dose limitation for cancer radiotherapy and chemoradiotherapy. Growth factors offer a novel means of mitigating normal tissue radiotoxicity. In particular, keratinocyte growth factor (rHuKGF), whose proliferative activity is restricted to epithelial cells, holds promise on the basis of the findings of preclinical models of epithelial cytoprotection and the clinical developments to date.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!